-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Buy on Medline, Lowers Price Target to $45

Benzinga·08/10/2026 15:32:18
Listen to the news
TD Cowen analyst Charles Rhyee maintains Medline (NASDAQ:MDLN) with a Buy and lowers the price target from $53 to $45.